Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Diphosphonates"" wg kryterium: Temat


Starter badań:

Tytuł:
Impact of bisphosphonate drugs on dental implant healing and peri-implant hard and soft tissues: a systematic review.
Autorzy:
Fiorillo L; Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.; Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania 'Luigi Vanvitelli', 80121, Naples, Italy.
Cicciù M; Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy. .
Tözüm TF; Department of Periodontics, University of Illinois at Chicago, College of Dentistry, Chicago, IL, USA.
D'Amico C; Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.
Oteri G; Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.
Cervino G; Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.
Pokaż więcej
Źródło:
BMC oral health [BMC Oral Health] 2022 Jul 17; Vol. 22 (1), pp. 291. Date of Electronic Publication: 2022 Jul 17.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Dental Implants*/adverse effects
Diphosphonates*/adverse effects
Dental Implantation, Endosseous/methods ; Dental Restoration Failure ; Humans ; Quality of Life
Czasopismo naukowe
Tytuł:
Computed Tomography-Based Investigation on the Effects of Intravenous Bisphosphonate Administration on Tooth Growth in a Minipig Animal Model.
Autorzy:
Poxleitner P; Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Voss PJ; Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Steybe D; Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Seibert LM; Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Zeiter S; AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos, Switzerland.
Stoddart MJ; AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos, Switzerland.
Schmelzeisen R; Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Otto S; Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University Munich, Lindwurmstr. 2a, 80337 Munich, Germany.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Jun 09; Vol. 58 (6). Date of Electronic Publication: 2022 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Diphosphonates*/adverse effects
Tomography, X-Ray Computed*
Animals ; Disease Models, Animal ; Humans ; Swine ; Swine, Miniature ; Tomography ; Zoledronic Acid
Czasopismo naukowe
Tytuł:
Bisphosphorylation of anhydrides - convenient access to bisphosphonates with a P-O-C-P motif.
Autorzy:
Zhang XY; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Li QW; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Yue HQ; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Wu ZQ; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Li J; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Li M; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Lu L; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Yang SD; State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, People's Republic of China.
Yang B; College of Chemistry and Chemical Engineering, Yantai University, Yantai, 264005, People's Republic of China. yangbin_.
Pokaż więcej
Źródło:
Chemical communications (Cambridge, England) [Chem Commun (Camb)] 2022 Jun 08; Vol. 58 (46), pp. 6665-6668. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Anhydrides*
Diphosphonates*
Catalysis ; Organophosphorus Compounds
Czasopismo naukowe
Tytuł:
Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p.
Autorzy:
Li X; Institute of Integrated Chinese and Western Medicine, The Hospital Affiliated to Jiangnan University, Wuxi, Jiangsu, China.
Xu R; Institute of Integrated Chinese and Western Medicine, The Hospital Affiliated to Jiangnan University, Wuxi, Jiangsu, China.
Ye JX; Institute of Integrated Chinese and Western Medicine, The Hospital Affiliated to Jiangnan University, Wuxi, Jiangsu, China.; Department of Orthopaedics and Central Laboratory, The Third Hospital Affiliated to Nantong University, Wuxi, Jiangsu, China.
Yuan FL; Institute of Integrated Chinese and Western Medicine, The Hospital Affiliated to Jiangnan University, Wuxi, Jiangsu, China.; Department of Orthopaedics, The Hospital Affiliated to Jiangnan University, Wuxi, Jiangsu, China.
Pokaż więcej
Źródło:
Bioengineered [Bioengineered] 2022 Apr; Vol. 13 (4), pp. 9741-9753.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Remodeling*/drug effects
Diphosphonates*/pharmacology
Diphosphonates*/therapeutic use
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Antagomirs/metabolism ; Female ; Humans ; Mice ; Osteoblasts/metabolism
Czasopismo naukowe
Tytuł:
Novel ferrocenylbisphosphonate hybrid compounds: Synthesis, characterization and potent activity against cancer cell lines.
Autorzy:
Anusionwu CG; Department of Chemical Sciences, University of Johannesburg, Doornfontein Campus, Johannesburg, South Africa.
Aderibigbe BA; Department of Chemistry, University of Fort Hare, Alice Campus, Eastern Cape, South Africa.
Adeyemi SA; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ubanako P; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Oselusi SO; School of Pharmacy, University of the Western Cape, Bellville, Cape Town 7535, South Africa.
Choonara YE; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Yangkou Mbianda X; Department of Chemical Sciences, University of Johannesburg, Doornfontein Campus, Johannesburg, South Africa. Electronic address: .
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2022 Mar 15; Vol. 58, pp. 116652. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Diphosphonates/*pharmacology
Ferrous Compounds/*pharmacology
Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Cell Proliferation/drug effects ; Cells, Cultured ; Diphosphonates/chemical synthesis ; Diphosphonates/chemistry ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Ferrous Compounds/chemical synthesis ; Ferrous Compounds/chemistry ; Mice ; Molecular Structure ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.
Autorzy:
Ebetino FH; BioVinc LLC, 2265 E. Foothill Blvd, Pasadena, CA 91107, USA; Department of Chemistry, University of Rochester, Rochester, NY 14617, USA; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK. Electronic address: .
Sun S; BioVinc LLC, 2265 E. Foothill Blvd, Pasadena, CA 91107, USA. Electronic address: .
Cherian P; BioVinc LLC, 2265 E. Foothill Blvd, Pasadena, CA 91107, USA.
Roshandel S; BioVinc LLC, 2265 E. Foothill Blvd, Pasadena, CA 91107, USA.
Neighbors JD; Pennsylvania State University, Hershey, PA, USA.
Hu E; BioVinc LLC, 2265 E. Foothill Blvd, Pasadena, CA 91107, USA.
Dunford JE; Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, The Oxford University Institute of Musculoskeletal Sciences, The Botnar Research Centre, Nuffield Orthopaedic Centre, Headington, Oxford OX3 7LD, UK.
Sedghizadeh PP; Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA 90089, USA.
McKenna CE; Department of Chemistry, University of Southern California, Los Angeles, CA 90089, USA.
Srinivasan V; Department of Chemistry, University of Rochester, Rochester, NY 14617, USA.
Boeckman RK; Department of Chemistry, University of Rochester, Rochester, NY 14617, USA.
Russell RGG; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK; Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, The Oxford University Institute of Musculoskeletal Sciences, The Botnar Research Centre, Nuffield Orthopaedic Centre, Headington, Oxford OX3 7LD, UK; Mellanby Centre for Musculoskeletal Research, University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło:
Bone [Bone] 2022 Mar; Vol. 156, pp. 116289. Date of Electronic Publication: 2021 Dec 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Neoplasms*/drug therapy
Diphosphonates*/pharmacology
Diphosphonates*/therapeutic use
Humans ; Mevalonic Acid/metabolism ; Nitrogen ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study.
Autorzy:
Schnabel A; Pädiatrische Rheumatologie, Universitätsklinikum Carl Gustav Carus, Dresden, Germany. Electronic address: .
Nashawi M; Pädiatrische Rheumatologie, Klinikum Stuttgart, Germany; Department of Pediatrics, King Abdulaziz University, Jeddah, Saudi Arabia.
Anderson C; Royal Hospital for Children and Young People, Edinburgh, United Kingdom.
Felsenstein S; Department of Infectious Disease and Immunology, Alder Hey Children's NHS Foundation Trust, United Kingdom.
Lamoudi M; Royal Hospital for Children and Young People, Edinburgh, United Kingdom.
Poole-Cowley J; Royal Hospital for Sick Children, Glasgow, United Kingdom.
Lindell E; University Hospital Crosshouse, Kilmarnock, United Kingdom.
Oates B; University Hospital Crosshouse, Kilmarnock, United Kingdom.
Fowlie P; Ninewells Hospital, Dundee, United Kingdom.
Walsh J; Royal Hospital for Sick Children, Glasgow, United Kingdom.
Ellis T; Pädiatrische Rheumatologie, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Hahn G; Department of Radiology, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Goldspink A; Raigmore Hospital, Inverness, United Kingdom.
Martin N; Royal Hospital for Sick Children, Glasgow, United Kingdom.
Mahmood K; Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
Hospach T; Pädiatrische Rheumatologie, Klinikum Stuttgart, Germany.
Lj M; Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
Hedrich CM; Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom; Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, United Kingdom. Electronic address: .
Pokaż więcej
Źródło:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 May; Vol. 238, pp. 109018. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Diphosphonates*/therapeutic use
Osteomyelitis*/drug therapy
Osteomyelitis*/pathology
Female ; Humans ; Pamidronate/therapeutic use ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors
SCR Disease Name:
Chronic recurrent multifocal osteomyelitis
Czasopismo naukowe
Tytuł:
Synthesis of Four Enantiomers of (1-Amino-3-Hydroxypropane-1,3-Diyl)Diphosphonic Acid as Diphosphonate Analogues of 4-Hydroxyglutamic Acid.
Autorzy:
Lebelt L; Bioorganic Chemistry Laboratory, Faculty of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
Głowacka IE; Bioorganic Chemistry Laboratory, Faculty of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
Piotrowska DG; Bioorganic Chemistry Laboratory, Faculty of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Apr 22; Vol. 27 (9). Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
Diphosphonates*
Organophosphonates*/chemistry
Esters ; Glutamates ; Stereoisomerism
Czasopismo naukowe
Tytuł:
Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial.
Autorzy:
Kim J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, 10 63-ro Yeongdengpo-gu, Seoul, 07345, Korea.
Kim KM; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173 Beon-gil Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Korea.
Lim S; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173 Beon-gil Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Korea.
Kang MI; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero Seocho-gu, Seoul, 06591, Korea.
Baek KH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, 10 63-ro Yeongdengpo-gu, Seoul, 07345, Korea. .
Min YK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Korea. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2022 Apr 11; Vol. 22 (1), pp. 99. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diphosphonates*/therapeutic use
Ibandronic Acid*/adverse effects
Osteoporosis, Postmenopausal*/drug therapy
Bone Density ; Bone Density Conservation Agents/adverse effects ; Bone Density Conservation Agents/therapeutic use ; Female ; Humans ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
Autorzy:
Banefelt J; Quantify Research, Stockholm, Sweden.
Timoshanko J; UCB Pharma, Slough, UK.
Söreskog E; Quantify Research, Stockholm, Sweden.; Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
Ortsäter G; Quantify Research, Stockholm, Sweden.
Moayyeri A; UCB Pharma, Brussels, Belgium.
Åkesson KE; Department of Clinical Sciences, Malmö Lund University, Malmö, Sweden.; Department of Orthopaedics, Skåne University Hospital, Malmö, Sweden.
Spångéus A; Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.; Department of Acute Internal Medicine and Geriatrics and Department of Endocrinology, Linköping University Hospital, Linköping, Sweden.
Libanati C; UCB Pharma, Brussels, Belgium.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jan; Vol. 37 (1), pp. 52-58. Date of Electronic Publication: 2021 Oct 21.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Density*
Diphosphonates*/adverse effects
Diphosphonates*/therapeutic use
Fractures, Bone*/etiology
Fractures, Bone*/prevention & control
Osteoporosis*/complications
Osteoporosis*/diagnostic imaging
Osteoporosis*/drug therapy
Hip Joint/*diagnostic imaging
Female ; Hip Joint/physiopathology ; Humans ; Middle Aged ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Common osteoporosis drug associated with increased rates of depression and anxiety.
Autorzy:
Keshishi D; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.
Makunts T; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.; Oak Ridge Institute of Science and Education Fellowship, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.
Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Dec 14; Vol. 11 (1), pp. 23956. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anxiety*/chemically induced
Anxiety*/epidemiology
Databases, Factual*
Depression*/chemically induced
Depression*/epidemiology
Diphosphonates*/administration & dosage
Diphosphonates*/adverse effects
Osteoporosis*/drug therapy
Osteoporosis*/epidemiology
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; United States/epidemiology ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł:
Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
Autorzy:
Rahman F; Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Nguyen TM; Department of Pharmacy, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Adekoya OA; Department of Pharmacy, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Campestre C; Department of Pharmacy, University of 'G. d'Annunzio' Chieti, Chieti, Italy.
Tortorella P; Department of Pharmacy, Science of Pharmacy, University 'A. Moro' Bari, Bari, Italy.
Sylte I; Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Winberg JO; Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 819-830.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents/*pharmacology
Catechols/*pharmacology
Diphosphonates/*pharmacology
Matrix Metalloproteinase Inhibitors/*pharmacology
Metalloendopeptidases/*antagonists & inhibitors
Anti-Bacterial Agents/chemical synthesis ; Anti-Bacterial Agents/chemistry ; Bacteria/enzymology ; Catechols/chemical synthesis ; Catechols/chemistry ; Diphosphonates/chemical synthesis ; Diphosphonates/chemistry ; Humans ; Matrix Metalloproteinase Inhibitors/chemical synthesis ; Matrix Metalloproteinase Inhibitors/chemistry ; Metalloendopeptidases/metabolism ; Microbial Sensitivity Tests ; Models, Molecular ; Molecular Structure ; THP-1 Cells
Czasopismo naukowe
Tytuł:
Optimal duration of adjuvant bisphosphonate treatment for high-risk early breast cancer: Results from a SUCCESS trial.
Autorzy:
Lu M; Department of Thyroid and Breast Surgery, Lishui People's Hospital, Lishui, China.
Ren B; Department of Thyroid and Breast Surgery, Lishui People's Hospital, Lishui, China.
Rao L; Department of Thyroid and Breast Surgery, Lishui People's Hospital, Lishui, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Feb; Vol. 13 (3), pp. 519-520. Date of Electronic Publication: 2022 Jan 02.
Typ publikacji:
Letter; Comment
MeSH Terms:
Breast Neoplasms*/drug therapy
Diphosphonates*/therapeutic use
Breast ; Chemotherapy, Adjuvant ; Female ; Humans
Opinia redakcyjna
Tytuł:
Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.
Autorzy:
Li JW; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Wang JY; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Yu RQ; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Huo L; Department of Orthodontics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Zheng LW; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2022 Jan 10; Vol. 15 (1), pp. 12. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*
Diphosphonates*
Animals ; Femur ; Rats ; Tooth Extraction ; Zoledronic Acid
Czasopismo naukowe
Tytuł:
Toxicity of zoledronic acid after intravenous administration: A retrospective study of 95 dogs.
Autorzy:
Brewer DJ; Fitzpatrick Referrals Oncology and Soft Tissue, Surrey, United Kingdom.; Small Animal Teaching Hospital, Leahurst, University of Liverpool, Neston, United Kingdom.
Macfarlane M; Fitzpatrick Referrals Oncology and Soft Tissue, Surrey, United Kingdom.; North Downs Specialist Referrals (NDSR), Bletchingley, United Kingdom.
O'Connell E; Small Animal Teaching Hospital, Leahurst, University of Liverpool, Neston, United Kingdom.
Bacon NJ; Fitzpatrick Referrals Oncology and Soft Tissue, Surrey, United Kingdom.; University of Surrey School of Veterinary Medicine, Surrey, United Kingdom.
Pokaż więcej
Źródło:
Journal of veterinary internal medicine [J Vet Intern Med] 2022 Jan; Vol. 36 (1), pp. 253-258. Date of Electronic Publication: 2021 Dec 03.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Diphosphonates*/adverse effects
Administration, Intravenous/veterinary ; Animals ; Dogs ; Imidazoles/adverse effects ; Infusions, Intravenous/veterinary ; Retrospective Studies ; Zoledronic Acid/adverse effects
Czasopismo naukowe
Tytuł:
Consider the Bisphosphonate Dose.
Autorzy:
Ott SM; Department of Medicine, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jan; Vol. 37 (1), pp. 1-2. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Diphosphonates*/adverse effects
Opinia redakcyjna
Tytuł:
The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials.
Autorzy:
Cheng X; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Wei J; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Ge Q; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Xing D; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Zhou X; State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, People's Republic of China.
Qian Y; Center of Stomatology, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Jiang G; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2021 Dec; Vol. 28 (1), pp. 37-53.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antineoplastic Agents/*administration & dosage
Bone Neoplasms/*drug therapy
Diphosphonates/*administration & dosage
Nanostructures/*chemistry
Osteolysis/*drug therapy
Osteolysis/*pathology
Antineoplastic Agents/adverse effects ; Biocompatible Materials ; Bone Neoplasms/secondary ; Delayed-Action Preparations ; Diphosphonates/adverse effects ; Drug Carriers/chemistry ; Drugs, Chinese Herbal/administration & dosage ; Genetic Therapy/methods ; Humans ; Hydrogels/administration & dosage ; Osteoclasts/metabolism ; Osteogenesis/physiology ; Phototherapy/methods ; Tissue Scaffolds
Czasopismo naukowe
Tytuł:
Osteoporosis, bisphosphonate use, and risk of moderate or worse hearing loss in women.
Autorzy:
Curhan SG; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Stankovic K; Harvard Medical School, Boston, Massachusetts, USA.; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Halpin C; Department of Otolaryngology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wang M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Eavey RD; Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Paik JM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts, USA.
Curhan GC; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2021 Nov; Vol. 69 (11), pp. 3103-3113. Date of Electronic Publication: 2021 May 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Diphosphonates*/adverse effects
Diphosphonates*/therapeutic use
Hearing/*drug effects
Hearing Loss/*epidemiology
Osteoporosis/*drug therapy
Adult ; Aged ; Audiometry/instrumentation ; Cohort Studies ; Female ; Hearing/physiology ; Humans ; Longitudinal Studies ; Middle Aged ; Risk Factors ; Self Report ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study.
Autorzy:
Viggers R; Steno Diabetes Center North Jutland, Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Al-Mashhadi Z; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Starup-Linde J; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Vestergaard P; Steno Diabetes Center North Jutland, Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Nov 19; Vol. 12, pp. 771426. Date of Electronic Publication: 2021 Nov 19 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alendronate/*adverse effects
Bone Density Conservation Agents/*adverse effects
Diabetes Mellitus, Type 2/*epidemiology
Diphosphonates/*adverse effects
Osteoporosis/*drug therapy
Aged ; Aged, 80 and over ; Alendronate/therapeutic use ; Bone Density Conservation Agents/therapeutic use ; Case-Control Studies ; Denmark/epidemiology ; Diabetes Mellitus, Type 2/chemically induced ; Diphosphonates/therapeutic use ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Registries
Czasopismo naukowe
Tytuł:
Tiludronic acid can be detected in blood and urine samples from Thoroughbred racehorses over 3 years after last administration.
Autorzy:
Riggs CM; Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Thompson SL; Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
So YM; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Wong JKY; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Wan TSM; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Robinson P; Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Stewart BD; Veterinary Regulation, Welfare and Biosecurity Policy, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Ho ENM; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Pokaż więcej
Źródło:
Equine veterinary journal [Equine Vet J] 2021 Nov; Vol. 53 (6), pp. 1287-1295. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Diphosphonates*
Animals ; Chromatography, High Pressure Liquid/veterinary ; Horses ; Mass Spectrometry/veterinary ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz